ITBZ20040048A1 - Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico - Google Patents

Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico

Info

Publication number
ITBZ20040048A1
ITBZ20040048A1 IT000048A ITBZ20040048A ITBZ20040048A1 IT BZ20040048 A1 ITBZ20040048 A1 IT BZ20040048A1 IT 000048 A IT000048 A IT 000048A IT BZ20040048 A ITBZ20040048 A IT BZ20040048A IT BZ20040048 A1 ITBZ20040048 A1 IT BZ20040048A1
Authority
IT
Italy
Prior art keywords
identification
particular reference
prostatic cancer
neoplastic transformation
neoplastic
Prior art date
Application number
IT000048A
Other languages
English (en)
Inventor
Saverio Bettuzzi
Arnaldo Corti
Original Assignee
Genprofiler
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genprofiler filed Critical Genprofiler
Priority to IT000048A priority Critical patent/ITBZ20040048A1/it
Publication of ITBZ20040048A1 publication Critical patent/ITBZ20040048A1/it
Priority to US11/664,792 priority patent/US20080009001A1/en
Priority to PCT/IB2005/002942 priority patent/WO2006038089A2/en
Priority to EP05801263A priority patent/EP1807534A2/en
Priority to RU2007114637/15A priority patent/RU2007114637A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
IT000048A 2004-10-06 2004-10-06 Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico ITBZ20040048A1 (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT000048A ITBZ20040048A1 (it) 2004-10-06 2004-10-06 Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico
US11/664,792 US20080009001A1 (en) 2004-10-06 2005-10-04 Method for Identification of Neoplastic Transformation with Particular Reference to Prostate Cancer
PCT/IB2005/002942 WO2006038089A2 (en) 2004-10-06 2005-10-04 Method for identification of neoplastic transformation with particular reference to prostate cancer
EP05801263A EP1807534A2 (en) 2004-10-06 2005-10-04 Method for identification of neoplastic transformation with particular reference to prostate cancer
RU2007114637/15A RU2007114637A (ru) 2004-10-06 2005-10-04 Способ идентификации неопластического перерождения преимущественно при раке предстательной железы

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000048A ITBZ20040048A1 (it) 2004-10-06 2004-10-06 Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico

Publications (1)

Publication Number Publication Date
ITBZ20040048A1 true ITBZ20040048A1 (it) 2005-01-06

Family

ID=36142912

Family Applications (1)

Application Number Title Priority Date Filing Date
IT000048A ITBZ20040048A1 (it) 2004-10-06 2004-10-06 Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico

Country Status (5)

Country Link
US (1) US20080009001A1 (it)
EP (1) EP1807534A2 (it)
IT (1) ITBZ20040048A1 (it)
RU (1) RU2007114637A (it)
WO (1) WO2006038089A2 (it)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008058018A2 (en) 2006-11-02 2008-05-15 Mayo Foundation For Medical Education And Research Predicting cancer outcome
CA2725978A1 (en) * 2008-05-28 2009-12-03 Genomedx Biosciences, Inc. Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer
US10407731B2 (en) 2008-05-30 2019-09-10 Mayo Foundation For Medical Education And Research Biomarker panels for predicting prostate cancer outcomes
WO2012007531A2 (en) 2010-07-13 2012-01-19 Frank Madeo Methods and compositions for diagnosing medical conditions
WO2013090620A1 (en) 2011-12-13 2013-06-20 Genomedx Biosciences, Inc. Cancer diagnostics using non-coding transcripts
ITMI20121066A1 (it) * 2012-06-19 2013-12-20 Euroclone S P A Predittore informatico per tumore alla prostata
DK3435084T3 (da) 2012-08-16 2023-05-30 Mayo Found Medical Education & Res Prostatakræftprognose under anvendelse af biomarkører
US10947598B2 (en) 2015-09-29 2021-03-16 Inserm (Institut National De La Sante Et De La Recherche Medicale) Methods for determining the metabolic status of lymphomas
WO2018039490A1 (en) 2016-08-24 2018-03-01 Genomedx Biosciences, Inc. Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy
AU2018210695A1 (en) 2017-01-20 2019-08-08 The University Of British Columbia Molecular subtyping, prognosis, and treatment of bladder cancer
EP3593140A4 (en) 2017-03-09 2021-01-06 Decipher Biosciences, Inc. SUBTYPING PROSTATE CANCER TO PREDICT RESPONSE TO HORMONE THERAPY
CA3062716A1 (en) 2017-05-12 2018-11-15 Decipher Biosciences, Inc. Genetic signatures to predict prostate cancer metastasis and identify tumor agressiveness

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6218529B1 (en) * 1995-07-31 2001-04-17 Urocor, Inc. Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6383808B1 (en) * 2000-09-11 2002-05-07 Isis Pharmaceuticals, Inc. Antisense inhibition of clusterin expression
US7622260B2 (en) * 2001-09-05 2009-11-24 The Brigham And Women's Hospital, Inc. Diagnostic and prognostic tests

Also Published As

Publication number Publication date
RU2007114637A (ru) 2008-11-20
EP1807534A2 (en) 2007-07-18
WO2006038089A2 (en) 2006-04-13
US20080009001A1 (en) 2008-01-10
WO2006038089A3 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
CY2019038I1 (el) Μεθοδοι για την κινητοποιηση κυτταρων προγεννητορων/βλαστοκυτταρων
NO20042159L (no) Cellokulturprosess
BR0203286B1 (pt) método para produzir vidro.
IS2940B (is) Mótefni gegn CD40
BR0206912B1 (pt) processo contìnuo para produzir ácido acético.
IS7137A (is) Samsett meðferð til meðhöndlunar á krabbameini
ITBZ20040048A1 (it) Metodo per l'identificazione della trasformazione neoplastica, con particolare riferimento al cancro prostatico
NO20033267D0 (no) Fremgangsmåter for öket produksjon av av pantothenat
EP1773883A4 (en) PRODUCTION OF ANTICANCER ANTIBODIES USING MASKED CANCER CELLS AS IMMUNOGENS
IS7239A (is) Aðferð til framleiðslu á essítalóprami
DK1506316T3 (da) Fremgangsmåde til forbedring af effektiviteten ved husdyrproduktion
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
AU2002351374A8 (en) Antibodies to treat cancer
AU2003302822A8 (en) Antibodies to treat cancer
ITMI20022185A1 (it) Processo per la preparazione di fenolo mediante idrodeossigenazione di benzendioli.
ITPC20030048A1 (it) Impianto per il lavaggio di veicoli migliorato, e relativo procedimento
ITMI20030346A1 (it) Procedimento per la produzione di mesitilene.
ITMI20041920A1 (it) Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
DE60201861D1 (de) Stahlherstellungsverfahren
ITMI20031670A1 (it) Processo per la preparazione di cilostazolo e di suoi intermedi.
GB2405335B (en) Use of rhodiola crenulata extract via the topical route
NO20033970D0 (no) Fremgangsmåter for öket produksjon av pantothenat
FI20010221A0 (fi) Menetelmä entsyymin uuttamiseksi
ITMI20040452A1 (it) Processo per la preparazione di oxcarbazepina
IT1318716B1 (it) Impianto per la produzione di calore accumulabile.